UNSPSC 51101667: Mepacrine or quinacrine

This classification denotes an antiprotozoal agent with the molecular formula C23H30ClN3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H0C805XYDE, chemically known as 1,4-pentanediamine, n4- (6-chloro-2-methoxy-9-acridinyl)-n1,n1-diethyl-, dihydrochloride but generally known as mepacrine, which bears US NIH Compound Identifier 237. European Medicines Agency schedules Mepacrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08744MIG.

UNSPSC 51101667 Mepacrine or quinacrine, a Commodity code, covers antimalarial and antiprotozoal pharmaceutical products that state and local health departments and county health systems procure for emergency preparedness, disease prevention, and community health programs. Recent solicitations show state and local buyers purchasing these and related pharmaceutical products through piggyback and cooperative purchasing arrangements, often bundled with other antimicrobials and emergency medical supplies to support public health initiatives and emergency response capabilities.

Activity under this code centers on state health departments and county health authorities. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 for Doxycycline Hyclate and Ciprofloxacin Hydrochloride (Bid Number 26-482DPH-PREPD-B-53392, total contract value $2,999,999.11 over 12 months with two renewal options). Seminole County, Florida issued an IFB (IFB60459723LAS) with a July 26, 2026 response date for Naloxone and Safe Drug Deactivation Systems, with 1,900 units of Naloxone and 800 systems required annually on a two-year term with one-year renewal option. Geographic activity appears concentrated in the Southeast and Midwest, with Illinois and Florida appearing as recent issuers. Cooperative purchasing vehicles and piggyback arrangements dominate the procurement method, and awards typically flow through established pharmaceutical distribution contracts rather than direct commodity buys.